Growth Metrics

Dna X (SONM) Receivables - Other (2020 - 2025)

Historic Receivables - Other for Dna X (SONM) over the last 6 years, with Q3 2025 value amounting to $9.8 million.

  • Dna X's Receivables - Other rose 12769.55% to $9.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.8 million, marking a year-over-year increase of 12769.55%. This contributed to the annual value of $7.1 million for FY2024, which is 64079.08% up from last year.
  • Dna X's Receivables - Other amounted to $9.8 million in Q3 2025, which was up 12769.55% from $7.0 million recorded in Q2 2025.
  • In the past 5 years, Dna X's Receivables - Other ranged from a high of $9.8 million in Q3 2025 and a low of $564000.0 during Q1 2024
  • In the last 5 years, Dna X's Receivables - Other had a median value of $2.5 million in 2022 and averaged $3.4 million.
  • In the last 5 years, Dna X's Receivables - Other tumbled by 7165.39% in 2022 and then surged by 104397.16% in 2025.
  • Quarter analysis of 5 years shows Dna X's Receivables - Other stood at $2.3 million in 2021, then grew by 0.62% to $2.3 million in 2022, then plummeted by 57.65% to $961000.0 in 2023, then surged by 640.79% to $7.1 million in 2024, then surged by 38.24% to $9.8 million in 2025.
  • Its last three reported values are $9.8 million in Q3 2025, $7.0 million for Q2 2025, and $6.5 million during Q1 2025.